**Core Concept:**
Long-standing obstruction due to enlarged tonsils and adenoids can lead to the development of obstructive sleep apnoea (OSA), a condition characterized by repeated episodes of complete or partial airway obstruction during sleep leading to disturbed sleep and daytime fatigue. OSA can have significant clinical implications, including cardiovascular morbidity, neurocognitive dysfunction, and increased risk of accidents.

**Why the Correct Answer is Right:**
The correct answer, **D**. Obstructive sleep apnoea, is the result of long-standing obstruction due to enlarged tonsils and adenoids. These enlarged structures can compress the airway, particularly in children, leading to OSA. In such cases, the airway becomes narrow, and the soft palate, uvula, and pharyngeal walls collapse during sleep, causing partial or complete blockage of the airway. This leads to hypoxia, hypercapnia, and sleep fragmentation, which contributes to the development of OSA.

**Why Each Wrong Option is Incorrect:**
A. Adenotonsillar hypertrophy (enlargement) is not the direct cause of chronic respiratory distress syndrome (CRDS). CRDS is a syndrome characterized by respiratory insufficiency due to pulmonary parenchymal injury, typically seen in neonates and infants.

B. While adenotonsillar hypertrophy can contribute to upper airway obstruction, it is not the sole cause of respiratory distress syndrome (RDS). RDS is a respiratory distress syndrome primarily affecting newborns, characterized by impaired gas exchange, and is often associated with prematurity and neonatal respiratory distress.

C. Enlarged tonsils and adenoids can cause upper airway obstruction, but they are not the primary cause of obstructive sleep apnoea and hypoventilation. OSA and hypoventilation are consequences of the obstruction due to adenotonsillar hypertrophy.

D. Chronic respiratory distress syndrome (CRDS) is a respiratory distress syndrome characterized by respiratory insufficiency due to parenchymal injury, typically in neonates and infants. This option is incorrect because it refers to a different condition (CRDS) caused by parenchymal injury rather than adenotonsillar hypertrophy.

E. While adenotonsillar hypertrophy can contribute to upper airway obstruction, it is not directly responsible for the development of pulmonary hypertension. Pulmonary hypertension is a separate condition characterized by increased blood vessel resistance and elevated pulmonary arterial pressure, typically caused by structural abnormalities, infections, or cardiac anomalies.

F. Hypoventilation is a condition characterized by inadequate respiration, which can be caused by various factors, including lung or chest wall abnormalities, neuromuscular disorders, or neuromuscular disorders. It is incorrect to attribute hypoventilation solely to adenotonsillar hypertrophy.

G. The term "pulmonary edema" refers to fluid accumulation in the lungs, which results from increased hydrostatic pressure or impaired capillary permeability. While adenotonsillar hypertrophy can contribute to upper airway obstruction, it is not directly responsible for pulmonary edema. Pulmonary edema has different mechanisms, involving increased hydrostatic pressure or impaired capillary permeability.

**Clinical Pearl:**
Adenotonsillar hypertrophy is a common cause